Chronic Disease
Chronic Disease
Modeling Health
Approximately half of all U.S. adults suffer from at least one chronic condition. Schaeffer Scholars are modeling the value of treatments and interventions that will reduce this burden.
Related Topics
Top Stories View All
Testimony
Testimony on Maintaining U.S. Biotech Competitiveness and Delivering Lifesaving Cures to Patients
In The News View All
HealthDay
Avoiding sleep drugs could improve older Americans’ health and longevity, USC Schaeffer research shows
Featured Experts: Hanke Heun-Johnson, Jason Doctor
The Academic Minute
Chapel discusses his “diabetes paradox” research showing health gains haven’t led to labor gains among people with diabetes
Featured Experts: Jack M. Chapel
Reuters
As insurers cut back on GLP-1 coverage, Peters says some patients are stretching doses
Featured Experts: Anne Peters
STAT
Expanded coverage of GLP-1s is “probably the single most effective policy” for improving public health, Goldman says
Featured Experts: Dana Goldman
KFF Heath News
Sood explains why many states capped insulin costs
Featured Experts: Neeraj Sood
Featured Testimony
Testimony on Incentivizing Chronic Disease Prevention and Treatment
Rebalancing the healthcare system to favor prevention and cures can potentially reduce the long-term burden of chronic diseases.
Experts: Anne Peters
Featured Article
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Experts: Dana Goldman, Bryan Tysinger